Brief: Aralez acquires U.S., Canadian rights to Zontivity from Merck

Procter & Gamble Health

07/09/2016 13:35

Sept 7 (Reuters) - Aralez Pharmaceuticals Inc  ARZ.TO  
    * Aralez acquires united states and canadian rights to 
Zontivity from Merck 
    * Says Merck will continue to distribute product on behalf 
of Aralez 
    * Says asset purchase agreement entered into between Merck, 
and Aralez Pharmaceuticals Trading DAC, unit of Aralez 
    * Says asset purchase agreement included an initial upfront 
payment of $25 million, which was paid from cash on hand 
    * Product rights, packaging, labeling and other 
responsibilities transferred to Aralez Pharmaceuticals Trading 
DAC 
 
Source text for Eikon:  ID:nCNWdkQrRa  
Further company coverage:  ARZ.TO  
 
 (Bangalore.newsroom@thomsonreuters.com)